Photo from Pierre Blanchard/X
Apr 27, 2024, 10:13
Pierre Blanchard: Declan Murphy’s view in the role of DRE in 2024 for prostate cancer
Pierre Blanchard, Radiation Oncology Clinical section chief at Gustave Roussy Cancer Institute, shared on X/Twitter:
“Declan Murphy’s view in the role of DRE in 2024 for prostate cancer
1. No role for screening
2. Almost no role pre-biopsy as MRI should be done instead to guide biopsies
3. Still a role for treatment decision? As most risk groups still include cT stage…”
Source: Pierre Blanchard/X
